Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$487K Hold
336,000
﹤0.01% 6107
2025
Q4
$457K Hold
336,000
﹤0.01% 6143
2025
Q3
$615K Hold
336,000
﹤0.01% 5933
2025
Q2
$1.06M Buy
+336,000
New +$862K ﹤0.01% 5407
2024
Q1
Sell
-158,900
Closed -$699K 9923
2023
Q4
$699K Buy
158,900
+125,000
+369% +$483K ﹤0.01% 4809
2023
Q3
$152K Hold
33,900
﹤0.01% 5552
2023
Q2
$108K Buy
+33,900
New +$122K ﹤0.01% 5951
2022
Q4
Sell
-91,400
Closed -$471K 11081
2022
Q3
$471K Hold
91,400
﹤0.01% 4389
2022
Q2
$533K Hold
91,400
﹤0.01% 4221
2022
Q1
$1.04M Buy
+91,400
New +$895K ﹤0.01% 4056

Other funds holding SABR

UBS Group's SABR Position: Q1 2026 in Review

UBS Group reduced its Sabre (SABR) stake by 43% in Q1 2026, selling an estimated $1.86M and leaving 1,839,666 shares worth $2.67M. The position accounts for ﹤0.01% of the portfolio, ranked #4701.

UBS Group first reported a position in SABR in Q4 2014 and has held it in 46 quarters since. The position peaked at $15M in Q4 2023. 242 funds tracked by Wall St. Rank hold SABR as of Q1 2026.

  • UBS Group held 1,839,666 shares of Sabre worth $2.67M as of Q1 2026.
  • UBS Group sold 1,395,298 Sabre shares in Q1 2026, an estimated $1.86M.
  • Sabre made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #4701 holding.
  • UBS Group first reported a position in Sabre in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Sabre position peaked at $15M in Q4 2023.
  • 242 funds tracked by Wall St. Rank held Sabre as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.